MEDICINES EVALUATION BOARD
The MEB is an independent authority that regulates the quality, efficacy and safety of medicines.
MEDICINES EVALUATION BOARD
Social Links:
Industry:
Health Care Pharmaceutical
Website Url:
http://www.english.cbg-meb.nl
Status:
Active
Contact:
+31 (0) 88 224 8000
Technology used in webpage:
LetsEncrypt Content Delivery Network Font Awesome Domain Not Resolving Apache ReCAPTCHA JsDelivr AJAX Libraries API BootstrapCDN Facebook Sharer
Similar Organizations
Accumulus Synergy
We are developing a global information exchange platform to accelerate the availability of safe and effective medicines.
All Day Med
All Day Med is an online pharmaceutical platform that enables its users to purchase prescription and generic drugs.
PhytoLab & Co.
PhytoLab is an independent, accredited and officially accredited testing laboratory for herbal medicines company in Vestenbergsgreuth.
Current Employees Featured
Official Site Inspections
http://www.english.cbg-meb.nl
- Host name: 178.22.85.168
- IP address: 178.22.85.168
- Location: Hendrik-Ido-Ambacht Netherlands
- Latitude: 51.8331
- Longitude: 4.6477
- Timezone: Europe/Amsterdam
- Postal: 3344

More informations about "Medicines Evaluation Board"
Home | Medicines Evaluation Board
The Medicines Evaluation Board (MEB) increases the fee rates for authorisation applications, authorisation changes and the annual ... Veterinary Medicinal Products Unit fees for 2024 โฆSee details»
About MEB > The organisation | Medicines Evaluation Board
The Medicines Evaluation Board (MEB) is responsible for assessing and monitoring the risk of medicines for human use, and for promoting the proper use of medicines. Meet our โฆSee details»
The Agency | Medicines Evaluation Board - CBG/MEB
Home | Medicines Information Bank | Medicines Evaluation Board
Oct 13, 2024ย ยท The Medicines Information Bank is managed by the Netherlands Medicines Authority MEB. It provides the official product information of all medicines which have a โฆSee details»
Board, organisation and financial affairs | MEB Annual Report
The MEB is placing a greater internal focus on diversity and inclusion and raising awareness by organising activities and sharing watching and listening tips. Facts and figures. The MEB had โฆSee details»
CBG/MEB
Als onafhankelijke autoriteit reguleert het College ter Beoordeling van Geneesmiddelen (CBG) de kwaliteit, werking en veiligheid van een medicijn, en stimuleert het CBG het juiste gebruik door โฆSee details»
Services and institutions | Ministry of Health, Welfare
The Medicines Evaluation Board (College ter Beoordeling van Geneesmiddelen or CBG) is an independent board that makes decisions about what medicines will be admitted to the market. โฆSee details»
Finding medicine in the Medicines Information Bank
Aug 17, 2021ย ยท The Medicines Information Bank contains information about all regular and homoeopathic medicines registered in the Netherlands. It includes information such as how to โฆSee details»
Our story: Good medicines used better - CBG/MEB
That is what the Medicines Evaluation Board (MEB) is working on each and every day. The MEB is an independent authority that regulates the quality, effects and safety of medicines and โฆSee details»
Over CBG > De organisatie | College ter Beoordeling van
Het College ter Beoordeling van Geneesmiddelen (CBG) is verantwoordelijk voor het beoordelen, bewaken en stimuleren van goed gebruik van medicijnen. Maak kennis met onze organisatie: โฆSee details»
CBG | MEB - bcfcareer.nl
Our work involves medicines available in the Netherlands and - together with our European colleagues - medicines available across Europe, from traditional to entirely new medicines. โฆSee details»
The year in overview: 2021 | MEB Annual Report - CBG Jaarverslag
CBG-MEB.nl was visited almost 6.7 million times in 2021. Placing the website in the top 15 of all (1,750) central government websites. Our Medicines Information Bank website โฆSee details»
CBG - UNICOM
The Medicines Evaluation Board Agency (agentschap College ter Beoordeling van Geneesmiddelen, in short: CBG-MEB) supports an independent Board in their tasks to โฆSee details»
The MEB in 2021 | MEB Annual Report - CBG Jaarverslag
May 1, 2021ย ยท โGeneral public awareness of the MEB increased significantly in 2021, in relation to issues such as the coronavirus vaccines and medicines and reports of possible adverse โฆSee details»
About MEB > Our Work | Medicines Evaluation Board - CBG/MEB
We assess medicines to determine whether they can be placed on the market, we monitor the adverse reactions and risks, and we promote the proper use of medicines: that is the core of โฆSee details»
aCBG (agentschap College ter Beoordeling van Geneesmiddelen)
Oct 15, 2024ย ยท De organisatie bestaat uit meer dan 400 medewerkers, waarvan velen met een medische of farmaceutische achtergrond. Samen werken zij dagelijks aan het beoordelen, โฆSee details»
The Medicines Evaluation Board and the National Health Care โฆ
May 9, 2019ย ยท Accelerating patient access to reimbursable innovative medicines has been on the wish list of the government, patient organisations, practitioners and the pharmaceutical โฆSee details»
About MEB | Medicines Evaluation Board - CBG/MEB
MEB Science Policy 2020 - 2024 (ENG) To provide guidance for our scientific activities, the MEB has identified eight themes we will invest in over the coming years. ... Publication | 12-05-2021See details»
NATIONAL CONTACTS - Heads of Medicines Agencies
Graadt van Roggenweg 500 NL - 3531 AH Utrecht Country Netherlands Phone +31 88 224 80 00 Fax +31 88 224 80 01 Website www.cbg-meb.nlSee details»
Help | Medicines Evaluation Board - CBG/MEB
On CBG-MEB.nl, the Medicines Evaluation Board offers information about the assessment, monitoring and proper use of medicines for humans and animals, and novel foods. CBG โฆSee details»